PMI
Picard Medical, Inc.
Price Chart
Latest Quote
$0.18
-0.01 (-4.66%)
Current Price
| Previous Close | $0.19 |
| Open | $0.17 |
| Day High | $0.19 |
| Day Low | $0.17 |
| Volume | 4,392,014 |
Stock Information
| Shares Outstanding | 93.35M |
| Total Debt | $3.27M |
| Cash Equivalents | $121K |
| Revenue | $5.47M |
| Net Income | $-28.28M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $17.00M |
| EPS (TTM) | $-0.76 |
| Exchange | ASE |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $19.97M |
| Sales | $5.47M |
| Income | $-28.28M |
| Book/sh | $-0.02 |
| Cash/sh | $0.00 |
| Employees | 75 |
Financial Ratios
| Quick Ratio | 0.06 |
| Current Ratio | 0.75 |
Returns & Margins
| ROA | -78.30% |
| Gross Margin | 7.84% |
| Operating Margin | -392.26% |
Ownership
| Insider Ownership | 53.01% |
| Institutional Ownership | 8.01% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -2.02 |
| P/S | 3.11 |
| P/B | -9.58 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.20 |
| SMA50 | $0.40 |
| SMA200 | $2.80 |
| RSI | 53.51 |
| ATR | 0.0731 |
| Shares Float | 39.51M |
| Short Float | 2.94% |
| Short Ratio | 0.06 |
| Rel Volume | 0.07 |
Performance History
| Week | +0.55% |
| Month | +13.75% |
| Quarter | -83.75% |
| 6 Months | -92.09% |
| YTD | -90.00% |
| 10 Years | -96.03% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.18 | 4,493,800 |
| 2026-06-17 | $0.19 | 13,483,400 |
| 2026-06-16 | $0.17 | 4,366,200 |
| 2026-06-15 | $0.17 | 6,073,800 |
| 2026-06-12 | $0.18 | 8,753,700 |
| 2026-06-11 | $0.18 | 7,278,800 |
| 2026-06-10 | $0.21 | 20,923,700 |
| 2026-06-09 | $0.32 | 40,393,800 |
| 2026-06-08 | $0.26 | 9,275,300 |
| 2026-06-05 | $0.26 | 16,072,400 |
| 2026-06-04 | $0.32 | 58,290,700 |
| 2026-06-03 | $0.31 | 237,459,600 |
| 2026-06-02 | $0.27 | 826,295,600 |
| 2026-06-01 | $0.17 | 23,528,600 |
| 2026-05-29 | $0.15 | 16,608,100 |
| 2026-05-28 | $0.15 | 4,335,300 |
| 2026-05-27 | $0.14 | 3,586,400 |
| 2026-05-26 | $0.14 | 6,772,400 |
| 2026-05-22 | $0.15 | 11,555,200 |
| 2026-05-21 | $0.14 | 5,257,400 |
| 2026-05-20 | $0.15 | 7,522,400 |
| 2026-05-19 | $0.16 | 15,131,300 |
About Picard Medical, Inc.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.
đ° Latest News
Philip Morris' IQOS Retains FDA Modified-Risk Authorization
Zacks âĸ 2026-04-20T14:16:00Z
PMI Q4 Earnings Call Highlights
MarketBeat âĸ 2026-03-25T23:08:44ZPicard Medical enters agreement for $50m senior secured notes
Medical Device Network âĸ 2025-12-26T11:25:16Z
Picard Medical (PMI): Assessing Valuation After Share Expansion and Dilution Concerns Spark Sell-Off
Simply Wall St. âĸ 2025-10-25T14:09:59Z
Sector Update: Health Care Stocks Higher Late Afternoon
MT Newswires âĸ 2025-08-29T19:59:58Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $5,144,000 | $4,503,000 | $7,354,000 | $9,101,000 |
| Cost Of Revenue | $5,144,000 | $4,503,000 | $7,354,000 | $9,101,000 |
| Total Revenue | $4,940,000 | $4,391,000 | $5,043,000 | $4,113,000 |
| Operating Revenue | $4,940,000 | $4,391,000 | $5,043,000 | $4,113,000 |
| Expenses | ||||
| Interest Expense | $5,393,000 | $3,067,000 | $140,000 | $5,000 |
| Total Expenses | $18,197,000 | $18,103,000 | $20,545,000 | $15,180,000 |
| Rent Expense Supplemental | $1,712,000 | $2,009,000 | $2,409,000 | $1,427,000 |
| Other Income Expense | $-6,023,000 | $-4,291,000 | $69,000 | $-94,000 |
| Other Non Operating Income Expenses | $1,017,000 | - | $69,000 | $-94,000 |
| Net Non Operating Interest Income Expense | $-7,687,000 | $-3,067,000 | $-138,000 | $4,000 |
| Total Other Finance Cost | $2,294,000 | - | - | - |
| Interest Expense Non Operating | $5,393,000 | $3,067,000 | $140,000 | $5,000 |
| Operating Expense | $13,053,000 | $13,600,000 | $13,191,000 | $6,079,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-27,002,000 | $-21,055,000 | $-15,569,000 | $-11,168,000 |
| Net Interest Income | $-7,687,000 | $-3,067,000 | $-138,000 | $4,000 |
| Normalized Income | $-22,243,830 | $-16,768,291 | $-15,569,000 | $-11,168,000 |
| Net Income From Continuing And Discontinued Operation | $-27,002,000 | $-21,055,000 | $-15,569,000 | $-11,168,000 |
| Total Operating Income As Reported | $-13,257,000 | $-13,712,000 | $-15,502,000 | $-11,067,000 |
| Net Income Common Stockholders | $-27,002,000 | $-23,737,000 | $-18,002,000 | $-12,670,000 |
| Net Income | $-27,002,000 | $-21,055,000 | $-15,569,000 | $-11,168,000 |
| Net Income Including Noncontrolling Interests | $-27,002,000 | $-21,055,000 | $-15,569,000 | $-11,168,000 |
| Net Income Continuous Operations | $-27,002,000 | $-21,055,000 | $-15,569,000 | $-11,168,000 |
| Pretax Income | $-26,967,000 | $-21,070,000 | $-15,571,000 | $-11,157,000 |
| Operating Income | $-13,257,000 | $-13,712,000 | $-15,502,000 | $-11,067,000 |
| Gross Profit | $-204,000 | $-112,000 | $-2,311,000 | $-4,988,000 |
| Interest Income | - | $0 | $2,000 | $9,000 |
| Interest Income Non Operating | - | $0 | $2,000 | $9,000 |
| Per Share | ||||
| Diluted EPS | $-0.75 | $-0.33 | $-0.25 | $-0.18 |
| Basic EPS | $-0.75 | $-0.33 | $-0.25 | $-0.18 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,264,830 | $-4,291 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-15,039,000 | $-13,169,000 | $-14,846,000 | $-10,607,000 |
| Total Unusual Items | $-6,023,000 | $-4,291,000 | - | - |
| Total Unusual Items Excluding Goodwill | $-6,023,000 | $-4,291,000 | - | - |
| Reconciled Depreciation | $512,000 | $543,000 | $585,000 | $545,000 |
| EBITDA (Bullshit earnings) | $-21,062,000 | $-17,460,000 | $-14,846,000 | $-10,607,000 |
| EBIT | $-21,574,000 | $-18,003,000 | $-15,431,000 | $-11,152,000 |
| Diluted Average Shares | $36,233,084 | $72,056,144 | $72,056,144 | $72,056,144 |
| Basic Average Shares | $36,233,084 | $72,056,144 | $72,056,144 | $72,056,144 |
| Diluted NI Availto Com Stockholders | $-27,002,000 | $-23,737,000 | $-18,002,000 | $-12,670,000 |
| Tax Provision | $35,000 | $-15,000 | $-2,000 | $11,000 |
| Gain On Sale Of Security | $-6,023,000 | $-4,291,000 | - | - |
| Research And Development | $3,049,000 | $3,380,000 | $2,213,000 | $1,902,000 |
| Selling General And Administration | $10,004,000 | $10,220,000 | $10,978,000 | $4,177,000 |
| Preferred Stock Dividends | - | $2,682,000 | $2,433,000 | $1,502,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,665,000 | $-24,947,000 | $-4,851,000 | $9,983,000 |
| Total Assets | $22,548,000 | $12,106,000 | $11,374,000 | $15,440,000 |
| Total Non Current Assets | $1,822,000 | $2,315,000 | $2,613,000 | $3,317,000 |
| Goodwill And Other Intangible Assets | $1,124,000 | $1,211,000 | $1,299,000 | $1,386,000 |
| Other Intangible Assets | $509,000 | $596,000 | $684,000 | $771,000 |
| Current Assets | $20,726,000 | $9,791,000 | $8,761,000 | $12,123,000 |
| Other Current Assets | $1,215,000 | $955,000 | $883,000 | $1,003,000 |
| Restricted Cash | $4,000,000 | $0 | - | - |
| Inventory | $7,303,000 | $8,115,000 | $6,893,000 | $7,326,000 |
| Receivables | $757,000 | $625,000 | $741,000 | $3,642,000 |
| Accounts Receivable | $623,000 | $513,000 | $629,000 | $882,000 |
| Cash Cash Equivalents And Short Term Investments | $7,451,000 | $96,000 | $244,000 | $152,000 |
| Cash And Cash Equivalents | $7,451,000 | $96,000 | $244,000 | $152,000 |
| Debt | ||||
| Total Debt | $6,975,000 | $20,927,000 | $9,411,000 | $1,959,000 |
| Long Term Debt And Capital Lease Obligation | $64,000 | $517,000 | $5,044,000 | $1,072,000 |
| Current Debt And Capital Lease Obligation | $6,911,000 | $20,410,000 | $4,367,000 | $887,000 |
| Current Debt | $6,448,000 | $19,976,000 | $4,057,000 | $620,000 |
| Other Current Borrowings | $1,000,000 | $19,976,000 | $4,057,000 | $620,000 |
| Net Debt | - | $19,880,000 | $8,095,000 | $468,000 |
| Long Term Debt | - | - | $4,282,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $18,759,000 | $35,842,000 | $14,926,000 | $4,071,000 |
| Total Non Current Liabilities Net Minority Interest | $64,000 | $517,000 | $5,714,000 | $1,072,000 |
| Current Liabilities | $18,695,000 | $35,325,000 | $9,212,000 | $2,999,000 |
| Other Current Liabilities | $8,341,000 | $7,252,000 | $64,000 | $25,000 |
| Current Notes Payable | $5,448,000 | $0 | - | - |
| Payables And Accrued Expenses | $2,869,000 | $6,722,000 | $4,011,000 | $1,839,000 |
| Interest Payable | $6,000 | $761,000 | $0 | - |
| Payables | $2,079,000 | $5,293,000 | $3,083,000 | $1,392,000 |
| Accounts Payable | $2,079,000 | $5,293,000 | $3,083,000 | $1,392,000 |
| Other Non Current Liabilities | - | - | $670,000 | - |
| Equity | ||||
| Common Stock Equity | $3,789,000 | $-44,001,000 | $-23,817,000 | $-8,896,000 |
| Total Equity Gross Minority Interest | $3,789,000 | $-23,736,000 | $-3,552,000 | $11,369,000 |
| Stockholders Equity | $3,789,000 | $-23,736,000 | $-3,552,000 | $11,369,000 |
| Gains Losses Not Affecting Retained Earnings | $228,000 | $278,000 | $293,000 | $398,000 |
| Other Equity Adjustments | $228,000 | $278,000 | $293,000 | $398,000 |
| Retained Earnings | $-76,843,000 | $-49,841,000 | $-28,786,000 | $-13,217,000 |
| Preferred Stock Equity | - | $20,265,000 | $20,265,000 | $20,265,000 |
| Preferred Securities Outside Stock Equity | - | $20,265,000 | $20,265,000 | $20,265,000 |
| Other | ||||
| Ordinary Shares Number | $73,701,176 | $72,056,144 | $72,056,144 | $72,056,144 |
| Share Issued | $73,701,176 | $72,056,144 | $72,056,144 | $72,056,144 |
| Tangible Book Value | $2,665,000 | $-45,212,000 | $-25,116,000 | $-10,282,000 |
| Invested Capital | $10,237,000 | $-24,025,000 | $-15,478,000 | $-8,276,000 |
| Working Capital | $2,031,000 | $-25,534,000 | $-451,000 | $9,124,000 |
| Capital Lease Obligations | $527,000 | $951,000 | $1,072,000 | $1,339,000 |
| Total Capitalization | $3,789,000 | $-23,736,000 | $730,000 | $11,369,000 |
| Additional Paid In Capital | $80,397,000 | $5,561,000 | $4,675,000 | $3,923,000 |
| Capital Stock | $7,000 | $20,266,000 | $20,266,000 | $20,265,000 |
| Common Stock | $7,000 | $1,000 | $1,000 | $0 |
| Preferred Stock | $0 | $20,265,000 | $20,265,000 | $20,265,000 |
| Long Term Capital Lease Obligation | $64,000 | $517,000 | $762,000 | $1,072,000 |
| Current Capital Lease Obligation | $463,000 | $434,000 | $310,000 | $267,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $574,000 | $941,000 | $770,000 | $248,000 |
| Current Accrued Expenses | $790,000 | $1,429,000 | $928,000 | $447,000 |
| Goodwill | $615,000 | $615,000 | $615,000 | $615,000 |
| Net PPE | $698,000 | $1,104,000 | $1,314,000 | $1,931,000 |
| Accumulated Depreciation | $-599,000 | $-523,000 | $-459,000 | $-293,000 |
| Gross PPE | $1,297,000 | $1,627,000 | $1,773,000 | $2,224,000 |
| Leases | $101,000 | $101,000 | $101,000 | $101,000 |
| Other Properties | $675,000 | $643,000 | $717,000 | $898,000 |
| Machinery Furniture Equipment | $521,000 | $883,000 | $955,000 | $1,225,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-2,833,000 | $-2,411,000 | $-2,191,000 | $-1,715,000 |
| Finished Goods | $1,478,000 | $1,443,000 | $1,704,000 | $2,438,000 |
| Work In Process | $2,533,000 | $2,764,000 | $1,093,000 | $1,288,000 |
| Raw Materials | $6,125,000 | $6,319,000 | $6,287,000 | $5,315,000 |
| Duefrom Related Parties Current | $134,000 | $112,000 | $112,000 | $2,760,000 |
| Non Current Accrued Expenses | - | $0 | $670,000 | $0 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-15,673,000 | $-11,874,000 | $-10,641,000 | $-10,752,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-15,673,000 | $-11,874,000 | $-10,634,000 | $-10,723,000 |
| Cash Flow From Continuing Operating Activities | $-15,673,000 | $-11,875,000 | $-10,634,000 | $-10,723,000 |
| Operating Gains Losses | $9,334,000 | $4,291,000 | $58,000 | - |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $0 | $-9,000 | $-37,000 |
| Cash Flow From Continuing Investing Activities | - | $0 | $-9,000 | $-37,000 |
| Capital Expenditure | - | - | $-7,000 | $-29,000 |
| Net Other Investing Changes | - | - | $-2,000 | $-8,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $17,444,000 | $0 | $2,650,000 | $0 |
| Financing Cash Flow | $27,078,000 | $11,741,000 | $10,840,000 | $5,524,000 |
| Cash Flow From Continuing Financing Activities | $27,078,000 | $11,741,000 | $10,840,000 | $5,524,000 |
| Net Other Financing Charges | $-1,488,000 | - | - | - |
| Net Common Stock Issuance | $17,444,000 | $0 | - | - |
| Common Stock Issuance | $17,444,000 | $0 | - | - |
| Net Preferred Stock Issuance | - | $0 | $2,650,000 | $0 |
| Preferred Stock Issuance | - | $0 | $2,650,000 | $0 |
| Other | ||||
| Repayment Of Debt | $-8,287,000 | $-1,378,000 | $-890,000 | $-26,000 |
| Issuance Of Debt | $19,409,000 | $13,119,000 | $9,080,000 | $5,550,000 |
| Interest Paid Supplemental Data | $259,000 | $1,000 | $1,000 | $2,000 |
| Income Tax Paid Supplemental Data | $4,000 | $0 | $1,000 | $2,000 |
| End Cash Position | $11,451,000 | $96,000 | $244,000 | $152,000 |
| Beginning Cash Position | $96,000 | $244,000 | $152,000 | $5,254,000 |
| Effect Of Exchange Rate Changes | $-50,000 | $-15,000 | $-105,000 | $134,000 |
| Changes In Cash | $11,405,000 | $-133,000 | $197,000 | $-5,236,000 |
| Net Issuance Payments Of Debt | $11,122,000 | $11,741,000 | $8,190,000 | $5,524,000 |
| Net Short Term Debt Issuance | $9,194,000 | $8,097,000 | $4,040,000 | $0 |
| Short Term Debt Payments | $-8,215,000 | $-1,322,000 | $-880,000 | $0 |
| Short Term Debt Issuance | $17,409,000 | $9,419,000 | $4,920,000 | $0 |
| Net Long Term Debt Issuance | $1,928,000 | $3,644,000 | $4,150,000 | $5,524,000 |
| Long Term Debt Payments | $-72,000 | $-56,000 | $-10,000 | $-26,000 |
| Long Term Debt Issuance | $2,000,000 | $3,700,000 | $4,160,000 | $5,550,000 |
| Change In Working Capital | $-3,202,000 | $963,000 | $3,280,000 | $-1,926,000 |
| Change In Other Current Liabilities | $-372,000 | $-311,000 | $0 | - |
| Change In Payables And Accrued Expense | $-2,850,000 | $2,560,000 | $3,353,000 | $-155,000 |
| Change In Accrued Expense | $361,000 | $350,000 | $1,747,000 | $-262,000 |
| Change In Payable | $-3,211,000 | $2,210,000 | $1,606,000 | $107,000 |
| Change In Account Payable | $-3,211,000 | $2,210,000 | $1,606,000 | $107,000 |
| Change In Prepaid Assets | $-250,000 | $-72,000 | $120,000 | $-390,000 |
| Change In Inventory | $390,000 | $-1,330,000 | $-446,000 | $-1,591,000 |
| Change In Receivables | $-120,000 | $116,000 | $253,000 | $210,000 |
| Changes In Account Receivables | $-120,000 | $116,000 | $253,000 | $210,000 |
| Other Non Cash Items | $4,525,000 | $2,390,000 | - | - |
| Stock Based Compensation | $754,000 | $886,000 | $133,000 | $148,000 |
| Unrealized Gain Loss On Investment Securities | $-1,017,000 | $0 | - | - |
| Provisionand Write Offof Assets | $423,000 | $108,000 | $879,000 | $1,678,000 |
| Depreciation Amortization Depletion | $512,000 | $543,000 | $585,000 | $545,000 |
| Depreciation And Amortization | $512,000 | $543,000 | $585,000 | $545,000 |
| Amortization Cash Flow | $87,000 | $87,000 | - | - |
| Amortization Of Intangibles | $87,000 | $87,000 | - | - |
| Depreciation | $425,000 | $456,000 | $585,000 | $545,000 |
| Gain Loss On Investment Securities | $9,334,000 | $4,291,000 | - | - |
| Net Income From Continuing Operations | $-27,002,000 | $-21,055,000 | $-15,569,000 | $-11,168,000 |
| Net PPE Purchase And Sale | - | $0 | $-7,000 | $-29,000 |
| Purchase Of PPE | - | $0 | $-7,000 | $-29,000 |
| Gain Loss On Sale Of PPE | - | $0 | $58,000 | $0 |
Fetched: 2026-06-18